Media-OutReach Newswire Expereo in 2024: Technology Investments as a Strategic Advantage in Paving Asia’s Path to Business Resilience
Media-OutReach Newswire Zuellig Pharma and Substipharm Biologics partner to expand access to IMOJEV® vaccine for Japanese encephalitis across Asia